257 related articles for article (PubMed ID: 25414343)
1. Identification by high-throughput imaging of the histone methyltransferase EHMT2 as an epigenetic regulator of VEGFA alternative splicing.
Salton M; Voss TC; Misteli T
Nucleic Acids Res; 2014 Dec; 42(22):13662-73. PubMed ID: 25414343
[TBL] [Abstract][Full Text] [Related]
2. Polycomb YY1 is a critical interface between epigenetic code and miRNA machinery after exposure to hypoxia in malignancy.
Infante T; Mancini FP; Lanza A; Soricelli A; de Nigris F; Napoli C
Biochim Biophys Acta; 2015 May; 1853(5):975-86. PubMed ID: 25644713
[TBL] [Abstract][Full Text] [Related]
3. Euchromatin histone methyltransferase II (EHMT2) regulates the expression of ras-related GTP binding C (RRAGC) protein.
Hwang S; Kim S; Kim K; Yeom J; Park S; Kim I
BMB Rep; 2020 Nov; 53(11):576-581. PubMed ID: 32684241
[TBL] [Abstract][Full Text] [Related]
4. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
Lee SH; Kim J; Kim WH; Lee YM
Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
[TBL] [Abstract][Full Text] [Related]
5. HP1 is involved in regulating the global impact of DNA methylation on alternative splicing.
Yearim A; Gelfman S; Shayevitch R; Melcer S; Glaich O; Mallm JP; Nissim-Rafinia M; Cohen AH; Rippe K; Meshorer E; Ast G
Cell Rep; 2015 Feb; 10(7):1122-34. PubMed ID: 25704815
[TBL] [Abstract][Full Text] [Related]
6. Exon resequencing of H3K9 methyltransferase complex genes, EHMT1, EHTM2 and WIZ, in Japanese autism subjects.
Balan S; Iwayama Y; Maekawa M; Toyota T; Ohnishi T; Toyoshima M; Shimamoto C; Esaki K; Yamada K; Iwata Y; Suzuki K; Ide M; Ota M; Fukuchi S; Tsujii M; Mori N; Shinkai Y; Yoshikawa T
Mol Autism; 2014; 5(1):49. PubMed ID: 25400900
[TBL] [Abstract][Full Text] [Related]
7. EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.
Renneville A; Van Galen P; Canver MC; McConkey M; Krill-Burger JM; Dorfman DM; Holson EB; Bernstein BE; Orkin SH; Bauer DE; Ebert BL
Blood; 2015 Oct; 126(16):1930-9. PubMed ID: 26320100
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of EHMT2 Induces a Robust Antiviral Response Against Foot-and-Mouth Disease and Vesicular Stomatitis Virus Infections in Bovine Cells.
Singh N; Ramĩrez-Carvajal L; de Los Santos T; Golding MC; Long CR
J Interferon Cytokine Res; 2016 Jan; 36(1):37-47. PubMed ID: 26418342
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-κB.
Park SE; Yi HJ; Suh N; Park YY; Koh JY; Jeong SY; Cho DH; Kim CS; Hwang JJ
Oncotarget; 2016 Jun; 7(26):39796-39808. PubMed ID: 27174920
[TBL] [Abstract][Full Text] [Related]
10. Cyclic stretch induces VEGFA alternative splicing via Serine/Arginine-Rich Splicing Factor 1.
Xie ZW; Chen YX; Long CF; Qi YX; Yao QP
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):43-50. PubMed ID: 29974845
[TBL] [Abstract][Full Text] [Related]
11. The lysine methyltransferase Ehmt2/G9a is dispensable for skeletal muscle development and regeneration.
Zhang RH; Judson RN; Liu DY; Kast J; Rossi FM
Skelet Muscle; 2016; 6():22. PubMed ID: 27239264
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 integrates G9a-mediated histone methylation.
Li Z; Jiao X; Di Sante G; Ertel A; Casimiro MC; Wang M; Katiyar S; Ju X; Klopfenstein DV; Tozeren A; Dampier W; Chepelev I; Jeltsch A; Pestell RG
Oncogene; 2019 May; 38(22):4232-4249. PubMed ID: 30718920
[TBL] [Abstract][Full Text] [Related]
13. Histone Methyltransferases G9a/
Souza BK; Freire NH; Monteiro TS; Herlinger AL; Jaeger M; Dalmolin MGS; de Farias CB; Gregianin L; Brunetto AT; Brunetto AL; Thiele CJ; Roesler R
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894922
[TBL] [Abstract][Full Text] [Related]
14. H3K9 histone methyltransferase G9a-mediated transcriptional activation of p21.
Oh ST; Kim KB; Chae YC; Kang JY; Hahn Y; Seo SB
FEBS Lett; 2014 Mar; 588(5):685-91. PubMed ID: 24492005
[TBL] [Abstract][Full Text] [Related]
15. EHMT2/G9a as an Epigenetic Target in Pediatric and Adult Brain Tumors.
Souza BK; Freire NH; Jaeger M; de Farias CB; Brunetto AL; Brunetto AT; Roesler R
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681949
[TBL] [Abstract][Full Text] [Related]
16. Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage.
Comiskey DF; Jacob AG; Singh RK; Tapia-Santos AS; Chandler DS
Nucleic Acids Res; 2015 Apr; 43(8):4202-18. PubMed ID: 25845590
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer's disease.
Zheng Y; Liu A; Wang ZJ; Cao Q; Wang W; Lin L; Ma K; Zhang F; Wei J; Matas E; Cheng J; Chen GJ; Wang X; Yan Z
Brain; 2019 Mar; 142(3):787-807. PubMed ID: 30668640
[TBL] [Abstract][Full Text] [Related]
18. EHMT2 is a metastasis regulator in breast cancer.
Kim K; Son MY; Jung CR; Kim DS; Cho HS
Biochem Biophys Res Commun; 2018 Feb; 496(2):758-762. PubMed ID: 29337058
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing of VEGFA is regulated by RBM10 in endometrial cancer.
Dou XQ; Chen XJ; Wen MX; Zhang SZ; Zhou Q; Zhang SQ
Kaohsiung J Med Sci; 2020 Jan; 36(1):13-19. PubMed ID: 31587503
[TBL] [Abstract][Full Text] [Related]
20. The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing.
Mozzetta C; Pontis J; Fritsch L; Robin P; Portoso M; Proux C; Margueron R; Ait-Si-Ali S
Mol Cell; 2014 Jan; 53(2):277-89. PubMed ID: 24389103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
